Page last updated: 2024-08-26

canthin-6-one and Leukemia, Myeloid, Acute

canthin-6-one has been researched along with Leukemia, Myeloid, Acute in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dias, DA; Ferreira, AT; Junior, MTR; JĂșnior, RTA; Justo, GZ; Lima, CS; Paredes-Gamero, EJ; Pilli, RA; Talhati, F; Torquato, HFV1

Other Studies

1 other study(ies) available for canthin-6-one and Leukemia, Myeloid, Acute

ArticleYear
A canthin-6-one derivative induces cell death by apoptosis/necroptosis-like with DNA damage in acute myeloid cells.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 145

    Topics: Antineoplastic Agents; Apoptosis; Carbolines; Cell Death; Cell Line, Tumor; DNA Damage; Humans; Indole Alkaloids; Leukemia, Myeloid, Acute; MAP Kinase Signaling System; Necroptosis; p38 Mitogen-Activated Protein Kinases; Reactive Oxygen Species

2022